Three writers. One standard.
Three beats, split the way the decisions actually split: which provider is worth ordering from, what the trials show, and what it actually costs. Each writer works under a consistent pen name — long-standing practice in science and medical journalism.
These are pen names and each profile says so in its first line. We attach no degrees, no institutional affiliations and no clinical credentials to them, because we do not have any to attach and inventing them is the oldest trick in this category. What is real is the sourcing: every figure, dose and claim traces to the trial, the label or the paper of record, checked against the database before it published. Judge the citations.
Beats are stable on purpose. The same name always covers the same ground, so if you disagree with how this site ranks a provider, you know exactly whose reasoning to argue with.
Nora Vance
Reviews & rankingsWhich sermorelin providers are actually worth ordering from, ranked plainly.
View profile →Adrian Osei
Evidence & trialsWhat the sermorelin research actually shows, and what is still unproven.
View profile →Simone Betts
Cost & accessWhat sermorelin actually costs, and how ordering it really works.
View profile →How we research and where we draw the line is set out in our methodology and editorial policy.